The future market for Covid-19 vaccines could be worth more than $10bn (£7.6bn) in annual revenues for pharmaceutical companies, according to industry experts, even though some drug-makers have pledged to provide their vaccines on a not-for-profit basis during this pandemic.
Matthew Harrison, an analyst at Morgan Stanley, estimates that even if only those who receive an annual flu jab take a Covid-19 shot, this would generate $10bn a year in revenues for the pharmaceutical industry in the US, Europe and other developed countries.
Evan Seigerman, an analyst at Credit Suisse, said the US market alone could be worth $10bn.
https://www.theguardian.com/business/2020/nov/05/future-market-for-covid-vaccines-could-be-worth-more-than-10bn-a-year
No comments:
Post a Comment